ConvergeHEALTH podcasts

Advancing pharmacovigilance

Glenn Carroll, safety leader and principal at Deloitte Consulting, details the obstacles that drug safety providers face today and how the competitive landscape is evolving as new entrants join the field. Carroll speaks about a recent collaboration between Deloitte and a big pharma company on an AI software-as-a-service platform.

Combining RCTs and RWD to improve patient outcomes

How can randomized controlled trials (RCTs) and real-world data (RWD) work together to improve patient outcomes? In this episode of the Real World Talk podcast, Deloitte’s Seshamalini Srinivasan, Laura Fernandes, and Karla Feghali talk about the importance of combining RWD and RCTs to bring lifesaving treatments to patients faster.

The past, present, and future of RWD

Real-world data is changing the pharma industry and allowing companies to maximize value while minimizing the time and money spent. In addition, technology is evolving, and new methodologies are being developed, but we still need to work on diversity and inclusion. In this episode of Real World Talk, Karla Feghali discusses a recent Deloitte report and the impact it has on the space.